UTMB

Inspiring graduation story: First-Generation and Legacy student George Fakes heads to Medical School

Retrieved on: 
Wednesday, April 24, 2024
Celts, Education, Leg, University, Beta Beta Beta, Pharmacy, NRG Stadium, Mentorship, Professor, Love, Parent, UTMB, 3D, STEM, Friends, UST, Family, Medicine, Student, Sibling, Nursing

His siblings, Stephanie Fakes ’18 and Nicole Fakes ’20, also majored in Biology and went to pharmacy school and medical school respectively.

Key Points: 
  • His siblings, Stephanie Fakes ’18 and Nicole Fakes ’20, also majored in Biology and went to pharmacy school and medical school respectively.
  • He spearheaded impactful service projects — in one of them, which involved 3D printing, he raised nearly $20,000 for Giving Tuesday.
  • “The Biology Department at UST has prepared me very well for the difficult and rigorous curriculum I will see in medical school,” he said.
  • Seeing their success and experience at UST opened my eyes to a school I was not even considering before.

Shokz Becomes Official Supplier of the UTMB World Series

Retrieved on: 
Friday, April 12, 2024
General Sports, Sports, Audio, Video, Hardware, Running, Consumer Electronics, Technology, Outdoors, Official, Ultra-Trail du Mont-Blanc, International, Hearing, Nature, Safety, Partnership, UTMB, Mont Blanc, Friends, Environment, Family, Noise, Electronics, Music, Athlete, Multimedia, Beauty

UTMB World Series and Shokz, the global consumer electronics brand and world’s leading pioneer in open-ear headphone technology, have today announced a partnership which will see Shokz become the Official Supplier and Official Headphones of the UTMB World Series.

Key Points: 
  • UTMB World Series and Shokz, the global consumer electronics brand and world’s leading pioneer in open-ear headphone technology, have today announced a partnership which will see Shokz become the Official Supplier and Official Headphones of the UTMB World Series.
  • As the Official Supplier and Official Headphones of the UTMB World Series, runners will have the chance to test Shokz products on-site at some events like Dacia UTMB® Mont-Blanc, The Canyons Endurance Run by UTMB®, Val d'Aran by UTMB®, Doi Inthanon Thailand by UTMB®, allowing them to experience the benefits of the products in real-life situations.
  • We are thrilled to welcome them as Official Supplier to inspire runners to go the extra mile,” said Frédéric Lénart, CEO, UTMB Group.
  • “We know how much the beauty and sound of nature, as well as the cheering of supporters and friends, can push you to the finish line.”
    “We’re absolutely thrilled to become an Official Supplier of the UTMB World Series,” said Daisy Cong, International Marketing Director at Shokz.

UTMB Health Selects Tendo's Data and Analytics Software

Retrieved on: 
Monday, April 8, 2024
UTHealth School of Dentistry, Health, Documentation, CDI, Caregiver, UTMB, Patient, Hospital, University, QDI, Tendō, Nursing

PHILADELPHIA, April 8, 2024 /PRNewswire/ -- Tendo, a software company creating seamless healthcare experiences for patients, clinicians, and caregivers while improving quality, financial, health, and operations outcomes, announces its newest customer, the University of Texas Medical Branch (UTMB Health).

Key Points: 
  • PHILADELPHIA, April 8, 2024 /PRNewswire/ -- Tendo, a software company creating seamless healthcare experiences for patients, clinicians, and caregivers while improving quality, financial, health, and operations outcomes, announces its newest customer, the University of Texas Medical Branch (UTMB Health).
  • Located in Galveston, TX, UTMB Health is a major academic health sciences center of global influence, a world-renowned research enterprise, and a growing, comprehensive health system with hospitals on four campuses and a network of clinics.
  • "UTMB Health already delivers quality clinical care.
  • Tendo's quality suite uses advanced analytics and AI to quickly and accurately identify opportunities for clinical documentation improvement while streamlining clinical workflows and simplifying clinician activities.

LBA HOSPITALITY AND OM SAI HOSPITALITY CELEBRATE THE GRAND OPENING OF RESIDENCE INN GALVESTON ISLAND

Retrieved on: 
Wednesday, March 20, 2024
LBA, Partnership, UTMB, Galveston College, Shriners Hospitals for Children, Pier, Residence Inn by Marriott, Heart, Hospital, Texas A&M University, Hotel

The opening of the Residence Inn Galveston Island is a significant milestone for LBA as it represents their first collaboration with the owners of Om Sai Hospitality.

Key Points: 
  • The opening of the Residence Inn Galveston Island is a significant milestone for LBA as it represents their first collaboration with the owners of Om Sai Hospitality.
  • This partnership is a natural extension of LBA's existing relationship with Details Hotel Group, also co-owners of Om Sai Hospitality.
  • "Their track record speaks for itself, and it's why Om Sai Hospitality confidently chose LBA as our go-to management partner for this new Galveston Island hotel.
  • Reservations for Residence Inn Galveston Island can be made online at www.marriott.com/hourg or by calling the hotel directly at 409-465-3191.

SYNAPS Dx Announces Prestigious Scientific Advisory Board to Guide Strategy and Commercialization of DISCERN™, Only Autopsy-Validated Test for Accurate Diagnosis of Alzheimer's Disease

Retrieved on: 
Wednesday, January 17, 2024
Research, Managed Care, Pharmaceutical, Mental Health, Medical Devices, Genetics, Science, Biotechnology, Neurology, Medical Supplies, Practice Management, Health, DISCERN, Patient, Dementia, Biology, ELISA, Multimedia, Culture, UTMB, Knowledge, Diagnosis, Neuron, Translational neuroscience, Memory, Software-defined, Neurodegenerative disease, Immunotherapy, Fibroblast, Skin, USC, Protein kinase C, SAB, Disease, Michigan State University, FDA, Therapy, Doctor of Philosophy, Inflammation, Master of Science, Brain, Ageing, Physician, Pharmaceutical industry

View the full release here: https://www.businesswire.com/news/home/20240117576710/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240117576710/en/
    • Alberto J. Espay, MD, MSc, chairman of the SAB, has over 300 published peer-reviewed research articles and 10 books on neurodegenerative diseases.
  • • Giulio Taglialatela, PhD, serves as the vice chair for research of the Department of Neurology and the director of the UTMB Mitchell Center for Neurodegenerative Diseases.
  • “We are honored to partner with such exceptional thought leaders who are shaping the future of brain health and advancing the biology of memory.
  • The AD-biomarker index also composes one of the three assays and tests skin fibroblasts from biopsies to culture to confluency.

Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update

Retrieved on: 
Tuesday, January 16, 2024
Patient, Injection, Traction, Health, Medicare, UTMB, Standard of care, Pain management, University, Spine, CPT, FDA, Physician, Letter, Epidural space, Patient safety, Education, MLSS, Pharmaceutical industry

I am proud to report we are making steady progress in advancing commercialization of the CompuFlo technology.

Key Points: 
  • I am proud to report we are making steady progress in advancing commercialization of the CompuFlo technology.
  • Several advisory sites were established across the US that implemented the CompuFlo technology in their practice.
  • The medical decision by physicians to use CompuFlo demonstrates the clinical utility and benefit of the technology in patient care.
  • A review and analysis of claims data shared by providers indicated that roughly one-third of claims have already received positive payor reimbursement.

Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures

Retrieved on: 
Friday, December 8, 2023
Baylor University, MD Anderson Cancer Center, Baylor College of Medicine, Cleveland Clinic, Trauma, Risk, UTHealth School of Dentistry, American Epilepsy Society, Physician, Injection, Electricity, Spinal cord, Hospital, MD, UTMB, Congress, University, Chronic pain, Nursing, Safety, MLSS

ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported it has commenced commercial sales of CompuFlo® disposables for use in neurostimulation spinal cord stimulator implantation procedures at the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital, expanding use of CompuFlo® within the institution beyond the labor and delivery department and training for residents in epidural needle placement and verification.

Key Points: 
  • A spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain.
  • An estimated 60,000 spinal cord stimulators are implanted each year.
  • Approval and adoption of the technology for neurostimulation spinal cord stimulator implantation follows a successful evaluation process by Dr. Patrick Karas, MD, a full-time faculty neurosurgeon at UTMB, operating at both the Galveston and Clear Lake campuses.
  • Dr. Karas completed 10 cases using the CompuFlo Epidural system, in which he reported 100% success and no complications.

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

Retrieved on: 
Thursday, November 30, 2023
Viremia, Infection, Immunology, Survival, Biotechnology, NIAID, Primate, Virus, Vaccination, Weight loss, Vaccine, Disease, UTMB, Congress, Human, SUDV, GeoVax, University, Death, Associate professor, EBOV, MARV, Cancer, Immunization, MVA

ATLANTA, GA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the presentation of data from recent preclinical studies of its vaccine candidates against Marburg virus and Sudan virus.

Key Points: 
  • The data were presented during the World Vaccine Congress, West Coast conference, being held in Santa Clara, CA from November 27-30, 2023.
  • Mark Newman, Ph.D., GeoVax Chief Scientific Officer, commented, “We are highly encouraged by the results of these studies of our MARV vaccine candidate.
  • The vaccine induced immune responses were characterized by MARV-specific binding and neutralizing antibodies as well as other effector functions like antibody-dependent phagocytosis.
  • The Angola strain is the most virulent strain of MARV characterized by a fatality rate of up to 90% in humans.

ChemDiv Forges Strategic Partnership with The University of Texas Medical Branch (UTMB) to Expand Its High-throughput Screening Research Capabilities

Retrieved on: 
Thursday, December 28, 2023
Research, Research and development, University, Chemical Diversity, UTHealth School of Dentistry, HTS, SAN, UTMB, Pharmaceutical industry

SAN DIEGO, Dec. 28, 2023 /PRNewswire/ -- ChemDiv, a global leader in drug discovery solutions, announces a strategic collaboration with the University of Texas Medical Branch (UTMB) to facilitate the expansion of its inventory and advance the institution's High-throughput Screening (HTS) research programs.

Key Points: 
  • SAN DIEGO, Dec. 28, 2023 /PRNewswire/ -- ChemDiv, a global leader in drug discovery solutions, announces a strategic collaboration with the University of Texas Medical Branch (UTMB) to facilitate the expansion of its inventory and advance the institution's High-throughput Screening (HTS) research programs.
  • ChemDiv's comprehensive suite of fully integrated Research & Development services offers UTMB unparalleled support in its pursuit of groundbreaking medical research.
  • "At ChemDiv, we are dedicated to catalyzing pioneering research, and our collaboration with UTMB exemplifies our commitment to advancing healthcare globally," said Bill Farley, CEO of ChemDiv.
  • "Our team's expertise and cutting-edge resources are poised to significantly augment UTMB's HTS research center, accelerating the discovery of novel therapeutic solutions."

Jalisco is Sought Out as Host for Major Global Events, Hospitality Openings

Retrieved on: 
Wednesday, December 20, 2023
Ultra-Trail du Mont-Blanc, Partnership, TIME, Agave, City, Male, Guadalajara Open, Science, Gay Games, Reproductive medicine, UTMB, Congress, COP, Heart, Mexican Academy, Tennis, Gold Award, FIL, Ariel Award, Teatro Degollado, Nature, Bahía de Banderas, ATP, Alchemy, IHG Hotels & Resorts, Web Cartoonists' Choice Awards, History, Tourism

JALISCO, Mexico, Dec. 20, 2023 /PRNewswire-PRWeb/ -- Having welcomed 28 million visitors in 2023, Jalisco – home of iconic Mexican heritage including mariachi and tequila – has established itself as an in-demand destination for high-profile events and congresses, and an attractive location for ultra-luxury hospitality offerings across its major tourism regions including Puerto Vallarta, Guadalajara, Costalegre and 12 Pueblos Magicos (Magical Towns). In its bicentennial year, the western Mexican state hosted numerous globally-attended events, such as Gay Games and the Ariel Awards, and celebrated the return of annual experiences like the Guadalajara Open. With an array of new luxury hotel openings, exciting sporting events and major medical congresses on the horizon for 2024 and beyond, it is clear that Jalisco is not slowing down anytime soon.

Key Points: 
  • With an array of new luxury hotel openings, exciting sporting events and major medical congresses on the horizon for 2024 and beyond, it is clear that Jalisco is not slowing down anytime soon.
  • With an array of new luxury hotel openings, exciting sporting events and major medical congresses on the horizon for 2024 and beyond, it is clear that Jalisco is not slowing down anytime soon.
  • A destination for travelers seeking a harmonious blend of luxury and cultural immersion, Jalisco welcomed notable hospitality offerings this year and unveiled plans for significant future openings.
  • Jalisco stands as a haven for the arts with a vibrant lineup of annual arts and culture events.